Longitudinal significance of six-minute walk test in patients with nontuberculous mycobacterial pulmonary disease: an observational study
Background The long-term exercise tolerance changes in patients with nontuberculous mycobacterial pulmonary disease (NTM-PD) are of great interest because of its chronic course. This study aimed to characterize the associations between changes over time in six-minute walking test (6MWT) parameters and clinical parameters in patients with NTM-PD. Methods Overall, 188 patients with NTM-PD, visiting outpatient clinics at Keio University Hospital from April 2012 to March 2020 were included in the study. Data were collected using the St. George’s Respiratory Questionnaire (SGRQ), pulmonary function test (PFT), blood tests, and the 6MWT at registration and at least once after that. The association of the anchors and clinical indicators with the 6MWT parameters was assessed. Results The median age [interquartile range] of the patients was 67 [63–74] years. The median baseline six-minute walk distance (6MWD) and final Borg scale (FBS) were 413 [361–470] m and 1 [0–2], respectively. In the correlation analysis, ΔSGRQ total/year (yr), Δforced vital capacity (FVC, % predicted)/yr, Δforced expiratory volume in 1 s ($ FEV_{1} $, % predicted)/yr, and Δdiffusing capacity for carbon monoxide ($ DL_{CO} $, % predicted)/yr correlated with both Δ6MWD/yr and ΔFBS/yr in the longitudinal analysis (|Rho| > 0.20). When stratified into three quantiles of changes in each anchor, the 6MWT parameters worsened over time in the bottom 25% group by mixed-effects model. Specifically, Δ6MWD was affected by SGRQ activity, SGRQ impacts, PFT (FVC, $ FEV_{1} $, and $ DL_{CO} $), and C-reactive protein (CRP). ΔFBS was affected by all SGRQ components, total score, and PFT. Anchor scores and variables at baseline that worsened Δ6MWD were higher SGRQ scores, lower FVC (% predicted), lower $ DL_{CO} $ (% predicted), higher Krebs von den Lungen-6, old age, and undergoing treatment at registration. Similarly, these clinical parameters and elevated CRP, excluding undergoing treatment at registration, worsened ΔFBS. Conclusions The decreased walking distance and exacerbation of dyspnea on exertion over time in patients with NTM-PD may reflect a deterioration of health-related quality of life and pulmonary function. Thus, the change in 6MWT over time can be used as an indicator to accurately assess the patient’s condition and tailor their healthcare environment..
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2023 |
|---|---|
| Erschienen: |
2023 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:23 |
|---|---|
| Enthalten in: |
BMC pulmonary medicine - 23(2023), 1 vom: 06. Juli |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Morita, Atsuho [VerfasserIn] |
|---|
| Links: |
Volltext [kostenfrei] |
|---|
| Themen: |
Health-related quality of life |
|---|
| Anmerkungen: |
© The Author(s) 2023 |
|---|
| doi: |
10.1186/s12890-023-02528-y |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
SPR052172996 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | SPR052172996 | ||
| 003 | DE-627 | ||
| 005 | 20230707064750.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 230707s2023 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1186/s12890-023-02528-y |2 doi | |
| 035 | |a (DE-627)SPR052172996 | ||
| 035 | |a (SPR)s12890-023-02528-y-e | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Morita, Atsuho |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Longitudinal significance of six-minute walk test in patients with nontuberculous mycobacterial pulmonary disease: an observational study |
| 264 | 1 | |c 2023 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a © The Author(s) 2023 | ||
| 520 | |a Background The long-term exercise tolerance changes in patients with nontuberculous mycobacterial pulmonary disease (NTM-PD) are of great interest because of its chronic course. This study aimed to characterize the associations between changes over time in six-minute walking test (6MWT) parameters and clinical parameters in patients with NTM-PD. Methods Overall, 188 patients with NTM-PD, visiting outpatient clinics at Keio University Hospital from April 2012 to March 2020 were included in the study. Data were collected using the St. George’s Respiratory Questionnaire (SGRQ), pulmonary function test (PFT), blood tests, and the 6MWT at registration and at least once after that. The association of the anchors and clinical indicators with the 6MWT parameters was assessed. Results The median age [interquartile range] of the patients was 67 [63–74] years. The median baseline six-minute walk distance (6MWD) and final Borg scale (FBS) were 413 [361–470] m and 1 [0–2], respectively. In the correlation analysis, ΔSGRQ total/year (yr), Δforced vital capacity (FVC, % predicted)/yr, Δforced expiratory volume in 1 s ($ FEV_{1} $, % predicted)/yr, and Δdiffusing capacity for carbon monoxide ($ DL_{CO} $, % predicted)/yr correlated with both Δ6MWD/yr and ΔFBS/yr in the longitudinal analysis (|Rho| > 0.20). When stratified into three quantiles of changes in each anchor, the 6MWT parameters worsened over time in the bottom 25% group by mixed-effects model. Specifically, Δ6MWD was affected by SGRQ activity, SGRQ impacts, PFT (FVC, $ FEV_{1} $, and $ DL_{CO} $), and C-reactive protein (CRP). ΔFBS was affected by all SGRQ components, total score, and PFT. Anchor scores and variables at baseline that worsened Δ6MWD were higher SGRQ scores, lower FVC (% predicted), lower $ DL_{CO} $ (% predicted), higher Krebs von den Lungen-6, old age, and undergoing treatment at registration. Similarly, these clinical parameters and elevated CRP, excluding undergoing treatment at registration, worsened ΔFBS. Conclusions The decreased walking distance and exacerbation of dyspnea on exertion over time in patients with NTM-PD may reflect a deterioration of health-related quality of life and pulmonary function. Thus, the change in 6MWT over time can be used as an indicator to accurately assess the patient’s condition and tailor their healthcare environment. | ||
| 650 | 4 | |a Nontuberculous mycobacteria |7 (dpeaa)DE-He213 | |
| 650 | 4 | |a Nontuberculous mycobacterial pulmonary disease |7 (dpeaa)DE-He213 | |
| 650 | 4 | |a Six-minute walk test |7 (dpeaa)DE-He213 | |
| 650 | 4 | |a Six-minute walk distance |7 (dpeaa)DE-He213 | |
| 650 | 4 | |a Health-related quality of life |7 (dpeaa)DE-He213 | |
| 650 | 4 | |a St. George’s respiratory questionnaire |7 (dpeaa)DE-He213 | |
| 700 | 1 | |a Yagi, Kazuma |4 aut | |
| 700 | 1 | |a Asakura, Takanori |4 aut | |
| 700 | 1 | |a Namkoong, Ho |4 aut | |
| 700 | 1 | |a Sato, Yasunori |4 aut | |
| 700 | 1 | |a Ogawa, Takunori |4 aut | |
| 700 | 1 | |a Kusumoto, Tatsuya |4 aut | |
| 700 | 1 | |a Suzuki, Shoji |4 aut | |
| 700 | 1 | |a Tanaka, Hiromu |4 aut | |
| 700 | 1 | |a Lee, Ho |4 aut | |
| 700 | 1 | |a Okamori, Satoshi |4 aut | |
| 700 | 1 | |a Azekawa, Shuhei |4 aut | |
| 700 | 1 | |a Nakagawara, Kensuke |4 aut | |
| 700 | 1 | |a Kaji, Masanori |4 aut | |
| 700 | 1 | |a Nagao, Genta |4 aut | |
| 700 | 1 | |a Funatsu, Yohei |4 aut | |
| 700 | 1 | |a Kimizuka, Yoshifumi |4 aut | |
| 700 | 1 | |a Kamata, Hirofumi |4 aut | |
| 700 | 1 | |a Nishimura, Tomoyasu |4 aut | |
| 700 | 1 | |a Ishii, Makoto |4 aut | |
| 700 | 1 | |a Fukunaga, Koichi |4 aut | |
| 700 | 1 | |a Hasegawa, Naoki |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t BMC pulmonary medicine |d London : BioMed Central, 2001 |g 23(2023), 1 vom: 06. Juli |w (DE-627)SPR027984389 |w (DE-600)2059871-3 |x 1471-2466 |7 nnns |
| 773 | 1 | 8 | |g volume:23 |g year:2023 |g number:1 |g day:06 |g month:07 |
| 856 | 4 | 0 | |u https://dx.doi.org/10.1186/s12890-023-02528-y |z kostenfrei |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_SPRINGER | ||
| 951 | |a AR | ||
| 952 | |d 23 |j 2023 |e 1 |b 06 |c 07 | ||